In July 2016 Alkor Bio Group’s Laboratory of Allergology completed the development and transferring to the market 28 new allergens and allergen mixes. For now the total number of 610 allergens, allergen mixes and allergen components has been launched by Alkor Bio Group.

At 2-3 of June Sequoia Genetics has represented a project “Multiplex duplex-mediated analysis based on fissionable probes” for the Startup Village competition by Skolkovo. 

F polymerase developed by Alkor Bio Group is enzyme allowing to amplify the DNA-fragments for more than 10000 bp with high fidelity and speed.

In April 2016 Alkor Bio Group's Laboratory of Allergology completed the development and transferred to the production 15 new allergens, including 1 recombinant allergen component of carrot - rDau c 1 Carrot.

In April Alkor Bio Group has received a grant of Foundation for Assistance to Small Innovative Enterprises (FASIE/Bortnik Fund) in the competition “Commercialization III” for the project “Genetic diagnostic of cystic fibrosis based on microchip-technology”.

In march Alkor Bio’s Laboratory of Molecular Diagnostics has finished development of the kits for  mutations determination in the CYP21A2 gene. Approximately 90% of the classic forms of CAH, salt-wasting and simple virilizing, are due to mutations in the CYP21A2 gene causing the disorder in functioning of the 21-hudroxylasa enzyme.